B-Cell Malignant Neoplasm — Trials

B-Cell Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,466 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,083
Recruiting: 1,077
Ph III recruiting: 121
Growth YoY: +2.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,167)

clinicaltrialsPublishedShowing 151–200 of 1,285 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04544592	UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL	recruiting	Phase 1 / Phase 2	45	University of Colorado, DenverOTHER	1	Sep 14, 2026	clinicaltrials
NCT04993690	A Study of LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma	recruiting	Phase 1	200	Guangzhou Lupeng Pharmaceutical Company LTD.INDUSTRY	1	Sep 14, 2026	clinicaltrials